Navigation Links
Sentara Remains Successful at Preventing Patient Infections

NORFOLK, Va., May 13 /PRNewswire/ -- Sentara Williamsburg Regional Medical Center has posted another year with not a single case of Ventilator Associated Pneumonia (VAP).  That makes six consecutive years without this hospital acquired infection that can lead to increased mortality and increased cost of care for some of the hospital's sickest patients.  Three other Sentara hospitals have eliminated common hospital infections in their Intensive Care Units for one year or more and infection rates across the system are trending down.

Recent national news coverage points to the 100,000 hospital deaths each year that are the direct result of patient infections obtained while in the hospital, which nationally are on the rise.  Hospital acquired infections not only compromise the health of the patient, but they add to the costly provision of health care.  Some estimates say that these infections add between 4.5 and 5.7 billion dollars to the annual cost of healthcare in this country. 

Sentara has worked for many years to measure, in real time, hospital infection rates across all its ICUs and apply proven medical best practices to reduce the incidence in its facilities.  Not only is Sentara seeing significant reductions of patient infections in its facilities, several of its hospitals are marking one or more years with zero infections that at one time were considered an inevitable part of providing care.  These infection rates are monitored according to Sentara's Intensive Care Infection Quality Measures.

For Sentara Williamsburg Regional Medical Center, six years without a VAP places it among a handful of providers in the country performing at that level.  After surpassing the five year milestone, national leadership organizations on healthcare quality promoted the facility as a model practice for infection control.  The Institute for Healthcare Improvement and VHA featured the ventilator care at Sentara Williamsburg during national conferences and in best practice publications.

When asked how it is done, lead intensivist physician Dr. John Kaiser points to consistent treatment and teamwork when caring for ventilator patients.  By consistently implementing a care "bundle" of procedures for patients, Sentara Williamsburg effectively has involved physicians, nurses and respiratory therapists as part of the team.  This clinical best practice has made a real difference for ICU patients.

Sentara Obici Hospital also recently marked its three year anniversary with no VAPs.  Further proof that quality care, performed consistently can have a dramatic impact on improving patient care.

Sentara Bayside Hospital is one of only five hospitals in Virginia and mentioned among the best in the country for protecting patients in the intensive care unit against life-threatening central line bloodstream infections in the March Consumer Reports magazine.  While not recognized in the magazine, Sentara Leigh Hospital has not had a single central line associated bloodstream infection in its ICU in the past year.

Between 2002 and 2009, the Sentara system's rate of central line-associated bloodstream infections fell from 3.68 to 0.42, a 93% reduction.  In that same period, VAPs fell 92% and significant reductions were seen in cases of Urinary Tract Infections in ICU patients across the system.

Sentara promotes a safe patient environment by promoting hand hygiene for all staff and physicians, promoting best care practices and in some cases actively screening patients for infection upon entry to the ICU.

For more health information and the latest press releases, go to the Sentara news page on

SOURCE Sentara
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Photos: Sentara Joins 4 U.S. Hospitals in International TARGIT Breast Cancer Trial
2. Sentara Cancer Network Earns National Accreditation
3. Organ Donor Shortage Remains Obstacle for Would-Be Transplant Patients Despite Better Medicine
4. Quality Colonoscopy Exam Remains Best Strategy for Detection of Polyps and Cancers According to Experts From the American College of Gastroenterology
5. Cardiac Disease in Women Remains Untreated for Decades
6. U.S. Naval Medical Research Center Proposed RESUS Clinical Trial in Trauma Patients Remains on FDA Hold
7. Senate Rejects Bulk Imports of Medicine from Canada, but Personal Importation Remains a Popular Option for U.S. Citizens
8. Awareness of Heart Disease in Women Remains Low
9. R&D Investment by U.S. Biopharmaceutical Companies Remains Strong Despite Ongoing Economic Challenges
10. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
11. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
Post Your Comments:
(Date:11/25/2015)... 2015 Kitov Pharma ceuticals ... a biopharmaceutical company focused on the development of therapeutic ... today announced the closing of its previously announced underwritten ... ), each representing 20 ordinary shares of the Company, ... ADSs and warrants were issued in a fixed combination ...
(Date:11/25/2015)...  Today AVACEN Medical announced the issue of United States patent No. ... ". This patent shields the company,s AVACEN 100 dry heat therapy medical device and specific methods ... Photo - ... ... ...
(Date:11/25/2015)... , Nov. 25, 2015 USP 800 ... drug preparations (e.g. pharmacists, pharmacy technicians, nurses, physicians, ... technicians). The chapter also covers all entities which ... pharmacies, hospitals, other healthcare institutions, patient treatment clinics, ... --> --> What is ...
Breaking Medicine Technology:
(Date:11/25/2015)... ... November 25, 2015 , ... For the first time, Vitalalert ... Organizations, One Beat ” campaign. The partnership between the two groups began in 2014 ... MAP International’s cause. , MAP International was founded in 1954 and is an international ...
(Date:11/25/2015)... ... ... On November 25, 2015, officials of Narconon Arrowhead , the drug rehabilitation ... new cutting edge recovery program that has been 50 years in the making. ... with the purpose to free addicts from the symptoms and negative behaviors of addiction. ...
(Date:11/25/2015)... ... ... Smiles by Stevens is pleased to announce the addition of Botox® for ... aware of the benefits of Botox® in the treatment of moderate facial wrinkling, few ... and pain as a result of Jaw Tension, TMJ (temporo-mandibular joint) disorder, and Bruxism ...
(Date:11/25/2015)... ... November 25, 2015 , ... In an ongoing Clinical Study conducted by an ... IL, UV Angel is evaluating the efficacy of its product and its disinfection protocol. ... 30 beds) from May 2014 through October 2015 at a 360-bed, acute-care, academic medical ...
(Date:11/25/2015)... Spring, Md (PRWEB) , ... November 25, 2015 ... ... Pulmonary Hypertension Association (PHA) announces the nation’s Periwinkle Pioneers, individuals and groups responsible ... history of this disease. The Periwinkle Pioneers, nominated by the public, will receive ...
Breaking Medicine News(10 mins):